News
An Australia and New Zealand Melanoma Trials Group (ANZMTG) clinical trial led by Peter MacCallum Cancer Centre investigators that aims to develop a novel treatment combination for a rare neuroendocrine cancer has received $AU1.8m funding from the Medical Research Future Fund.
Peter Mac has signed a Memorandum of Understanding with the ACT Government and Australian National University (ANU) to expand access to clinical trials and genomics services for ACT cancer patients.
Peter Mac’s Professor Joe Trapani, has been appointed head of a major new laboratory focused on immunotherapy. Prof Trapani is Director of the new Centre for Cancer Immunotherapy, which is a partnership between Peter Mac, the VCCC and University of Melbourne and is scheduled to open later this year.
